EcoDrugPlus

Tubulin Beta Chain

Ensembl ID : ENSMZEG00005018259
Gene Symbol: LOC101469831
3 Cross references
183 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSMZEG00005005670
Gene Symbol: LOC101468168
2 Cross references
184 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSMZEG00005025168
Gene Symbol: LOC101473957
3 Cross references
305 Possible Orthologues:

Type-2 Angiotensin Ii Receptor

Ensembl ID : ENSMZEG00005007076
Gene Symbol: LOC101486923
3 Cross references
185 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMZEG00005019566
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMZEG00005028506
Gene Symbol: LOC101476383
3 Cross references
201 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMZEG00005023676
Gene Symbol: TYR
1 Cross references
201 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSMZEG00005017439
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSMZEG00005018982
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSMZEG00005018995
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Jak2

Ensembl ID : ENSMZEG00005016984
Gene Symbol: LOC101468325
3 Cross references
199 Possible Orthologues:

Tyrosine-Protein Kinase Jak2

Ensembl ID : ENSMZEG00005013360
Gene Symbol: LOC101469715
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).